[1]
Q. Chang, M. Zhu, Z. Zuo, M. Chow, W.K. Ho. High-performance liquid chromatographic method for simultaneous determination of hawthorn active components in rat plasma. J Chromatogr B Biomed Sci Appl 760 (2001) 227-235.
DOI: 10.1016/s0378-4347(01)00273-0
Google Scholar
[2]
U. Svedstrm, H. Vuorela, R. Kostiainen, I. Laakso, R. Hiltunen. Fractionation of polyphenols in hawthorn into polymeric procyanidins, phenolic acids and flavonoids prior to high-performance liquid chromatographic analysis. J Chromatogr A Plant Analysis 1112 (2006) 103-111.
DOI: 10.1016/j.chroma.2005.12.080
Google Scholar
[3]
M. Zcan, H. HacIseferogullarI, T. Marakoglu, D. Arslan. Hawthorn (Crataegus spp.) fruit: some physical and chemical properties. J. Food Eng 69 (2005) 409-413.
DOI: 10.1016/j.jfoodeng.2004.08.032
Google Scholar
[4]
P. Liu, B. Yang, H. Kallio. Characterization of phenolic compounds in Chinese hawthorn (Crataegus pinnatifida Bge. var. major) fruit by high performance liquid chromatography-electrospray ionization mass spectrometry. Food Chem 121 (2010) 1188-1197.
DOI: 10.1016/j.foodchem.2010.02.002
Google Scholar
[5]
V.M. Tadic, S. Dobric, G.M. Markovic, S.M. Dordevic, I.A. Arsic, N.R. Menkovic, T. Stevic. Anti-inflammatory, gastroprotective, free-radical-scavenging, and antimicrobial activities of hawthorn berries ethanol extract. J Agric Food Chem 56 (2008) 7700-7709.
DOI: 10.1021/jf801668c
Google Scholar
[6]
F. Aln-Ruiz, M.S. Garca-Falcn, M.C. Prez-Lamela, E. Martnez-Carballo, J. Simal-Gndara. Influence of major polyphenols on antioxidant activity in Menca and Brancellao red wines. Food Chemistry 113 (2009) 53-60.
DOI: 10.1016/j.foodchem.2008.07.038
Google Scholar
[7]
A. Sokl-Letowska, J. Oszmianski, A. Wojdylo. Antioxidant activity of the phenolic compounds of hawthorn, pine and skullcap. Food Chem 103 (2007) 853-859.
DOI: 10.1016/j.foodchem.2006.09.036
Google Scholar
[8]
J.M. Rigelsky, B.V. Sweet. Hawthorn: pharmacology and therapeutic uses. Am J Health Syst Pharm 59 (2002) 417-422.
DOI: 10.1093/ajhp/59.5.417
Google Scholar
[9]
C. Quettier-Deleu, G. Voiselle, J.C. Fruchart, P. Duriez, E. Teissier, F. Bailleul, J. Vasseur, F. Trotin. Hawthorn extracts inhibit LDL oxidation. Pharmazie 58 (2003) 577-581.
Google Scholar
[10]
R. Jayalakshmi, C.J. Thirupurasundari, S.N. Devaraj. Pretreatment with alcoholic extract of Crataegus oxycantha (AEC) activates mitochondrial protection during isoproterenol - induced myocardial infarction in rats. Mol Cell Biochem 292 (2006) 59-67.
DOI: 10.1007/s11010-006-9218-3
Google Scholar
[11]
S.H. Kim, K.W. Kang, K.W. Kim, N.D. Kim. Procyanidins in crataegus extract evoke endothelium-dependent vasorelaxation in rat aorta.Life Sci 67 (2000) 121-131.
DOI: 10.1016/s0024-3205(00)00608-1
Google Scholar
[12]
S. Popping, H. Rose, I. Ionescu, Y. Fischer, H. Kammermeier. Effect of a hawthorn extract on contraction and energy turnover of isolated rat cardiomyocytes. Arzneimittelforschung 45 (1995) 1157-1161.
Google Scholar
[13]
W. Vierling, N. Brand, F. Gaedcke, K.H. Sensch, E. Schneider, M. Scholz. Investigation of the pharmaceutical and pharmacological equivalence of different Hawthorn extracts. Phytomedicine 10 (2003) 8-16.
DOI: 10.1078/094471103321648601
Google Scholar
[14]
C.J. Holubarsch, W.S. Colucci, T. Meinertz, W. Gaus, M. Tendera. The efficacy and safety of Crataegus extract WS 1442 in patients with heart failure: the SPICE trial. Eur J Heart Fail 10 (2008) 1255-63.
DOI: 10.1016/j.ejheart.2008.10.004
Google Scholar
[15]
M.H. Pittler, K. Schmidt, E. Ernst. Hawthorn extract for treating chronic heart failure: meta-analysis of randomized trials. Am J Med 114 (2003) 665-674.
DOI: 10.1016/s0002-9343(03)00131-1
Google Scholar
[16]
S.R. Long, R.A. Carey, K.M. Crofoot, P.J. Proteau, T.M. Filtz. Effect of hawthorn (Crataegus oxycantha) crude extract and chromatographic fractions on multiple activities in a cultured cardiomyocyte assay. Phytomedicine 13 (2006) 643-50.
DOI: 10.1016/j.phymed.2006.01.005
Google Scholar
[17]
J.H.K. Vogel, et al. Integrating Complementary Medicine Into Cardiovascular Medicine: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. JACC 46 (2005) 184-221.
Google Scholar
[18]
V. Schulz, R. H nsel, V.E. Tyler, Rational phytotherapy: a physician's guide to herbal medicine, Routledge, 2001.
Google Scholar
[19]
R. Tankanow, H.R. Tamer, D.S. Streetman, S.G. Smith, J.L. Welton, T. Annesley, K.D. Aaronson, B.E. Bleske. Interaction study between digoxin and a preparation of hawthorn (Crataegus oxyacantha). J Clin Pharmacol 43 (2003) 637-642.
DOI: 10.1177/0091270003043006009
Google Scholar
[20]
A. Muller, W. Linke, W. Klaus. Crataegus extract blocks potassium currents in guinea pig ventricular cardiac myocytes. Planta Med 65 (1999) 335-339.
DOI: 10.1055/s-1999-13997
Google Scholar
[21]
S. Rajendran, P.D. Deepalakshmi, K. Parasakthy, H. Devaraj, S.N. Devaraj. Effect of tincture of Crataegus on the LDL-receptor activity of hepatic plasma membrane of rats fed an atherogenic diet. Atherosclerosis 123 (1996) 235-241.
DOI: 10.1016/0021-9150(96)05813-3
Google Scholar
[22]
S. Shanthi, K. Parasakthy, P.D. Deepalakshmi, S.N. Devaraj. Hypolipidemic activity of tincture of Crataegus in rats. Indian J Biochem Biophys 31 (1994) 143-146.
Google Scholar
[23]
R. Stocker, J.F. Keaney Jr, Role of oxidative modifications in atherosclerosis. Physiol Rev 84 (2004) 1381-1478.
DOI: 10.1152/physrev.00047.2003
Google Scholar
[24]
C.-Y. Kwok, C.N.-Y. Wong, M.Y.-C. Yau, P.H.-F. Yu, A.L.S. Au, C.C.-W. Poon, S.-W. Seto, T.-Y. Lam, Y.-W. Kwan, S.-W. Chan. Consumption of dried fruit of Crataegus pinnatifida (hawthorn) suppresses high-cholesterol diet-induced hypercholesterolemia in rats. J Funct Foods 2 (2010) 179-186.
DOI: 10.1016/j.jff.2010.04.006
Google Scholar
[25]
A.F. Walker, G. Marakis, E. Simpson, J.L. Hope, P.A. Robinson, M. Hassanein, H.C.R. Simpson. Hypotensive effects of hawthorn for patients with diabetes taking prescription drugs: a randomised controlled trial. Br J Gen Pract 56 (2006) 437-443.
Google Scholar
[26]
R. Jayalakshmi, D.S. Niranjali. Cardioprotective effect of tincture of Crataegus on isoproterenol-induced myocardial infarction in rats. J Pharm Pharmacol 56 (2004) 921-926.
DOI: 10.1211/0022357023745
Google Scholar
[27]
B. Somanadhan, G. Varughese, P. Palpu, R. Sreedharan, L. Gudiksen, U.W. Smitt, U. Nyman. An ethnopharmacological survey for potential angiotensin converting enzyme inhibitors from Indian medicinal plants. J Ethnopharmacol 65 (1999) 103-112.
DOI: 10.1016/s0378-8741(98)00201-3
Google Scholar
[28]
J. Inokuchi, H. Okabe, T. Yamauchi, A. Nagamatsu. Inhibitors of angiotensin converting enzyme in crude drugs. I. Chem Pharm Bull (Tokyo) 32 (1984) 3615-3619.
DOI: 10.1248/cpb.32.3615
Google Scholar
[29]
Lacaille-Dubois, U. Franck, H. Wagner. Search for potential angiotensin converting enzyme (ACE)-inhibitors from plants. Phytomedicine 8 (2001) 47-52.
DOI: 10.1078/0944-7113-00003
Google Scholar